Abstract 4370214: Atrial 18F-Fludeoxyglucose Avidity is Higher in Persistent than Paroxysmal Atrial Fibrillation

Background: Atrial fibrillation (AF) is marked by underlying inflammation and metabolic changes. Atrial 18F-Fludeoxyglucose (FDG) positron emission tomography (PET) can be used to assess these changes. Previous studies show increased FDG avidity in AF. Aim: We aim to investigate atrial uptake differences between paroxysmal AF (pAF) and persistent AF (perAF). Hypothesis: Patients with perAF exhibit a greater atrial FDG-PET avidity and demonstrate higher quantitative uptake measures compared to those with pAF. Methods: Patients undergoing FDG-PET for the evaluation of cardiac sarcoidosis (CS) were assessed for atrial avidity. Atrial FDG uptake, a semi-quantitative measure, was quantified using standardized uptake value (SUV)-mean, SUV-max, and normalized to the blood pool as the target-to-background ratio (TBR). Qualitatively, intensity with respect to liver uptake (less vs equal or greater), pattern (focal vs diffuse), and location were reported. AF types were determined using patient’s electronic medical records. Results: One hundred and twenty-six patients (age 67 ± 12 years, 26% female, BMI 29.8 ± 6.5 kg/m2) were included in the study. 35 pts (27.4%) met diagnostic criteria for cardiac sarcoidosis (CS). 79 (62.7%) patients had pAF, 39 (31%) had perAF, 8 (6.3%) had an unspecified subtype. Atrial avidity was seen in 45 patients and distributed accordingly: 30 in the right atrium, 13 bi-atrial, and 2 left atrial. Avidity had a predominant diffuse pattern (66.7%) with intensity equal or greater than the liver’s (62%). 23 (58%) of the avid atria were in perAF patients while only 22 (38%) were in pAF patients. Quantitively, aTBRmax was significantly higher in perAF group (1.35 ± 0.51 vs 1.14 ± 0.39, p=0.03). PerAF was associated with a higher aTBRmax (B=0.2, CI 0.03-0.37, p=0.02) after adjusting for cardiac sarcoidosis. Conclusion: Persistent AF is associated with higher qualitative and quantitative atrial FDG-PET avidity compared to paroxysmal AF. Additional studies are needed to better understand causality and mechanisms behind these associations.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-11-03
DOI
https://doi.org/10.1161/circ.152.suppl_3.4370214
Primary Topic
Sarcoidosis and Beryllium Toxicity Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4370214: Atrial 18F-Fludeoxyglucose Avidity is Higher in Persistent than Paroxysmal Atrial Fibrillation

NAZEM W. AKOUM, Nadia Chamoun, Efstathia Andrikopoulou, Murat Sadıç et al.
Circulation
Sarcoidosis and Beryllium Toxicity Research
article

Abstract 4370214: Atrial 18F-Fludeoxyglucose Avidity is Higher in Persistent than Paroxysmal Atrial Fibrillation

NAZEM W. AKOUM, Nadia Chamoun, Efstathia Andrikopoulou, Murat Sadıç, Romanos Haykal, Yaacoub Chahine, Ahmad Kassar, Hala Al Yasiri, Tori Hensley
article en

Abstract

Background: Atrial fibrillation (AF) is marked by underlying inflammation and metabolic changes. Atrial 18F-Fludeoxyglucose (FDG) positron emission tomography (PET) can be used to assess these changes. Previous studies show increased FDG avidity in AF. Aim: We aim to investigate atrial uptake differences between paroxysmal AF (pAF) and persistent AF (perAF). Hypothesis: Patients with perAF exhibit a greater atrial FDG-PET avidity and demonstrate higher quantitative uptake measures compared to those with pAF. Methods: Patients undergoing FDG-PET for the evaluation of cardiac sarcoidosis (CS) were assessed for atrial avidity. Atrial FDG uptake, a semi-quantitative measure, was quantified using standardized uptake value (SUV)-mean, SUV-max, and normalized to the blood pool as the target-to-background ratio (TBR). Qualitatively, intensity with respect to liver uptake (less vs equal or greater), pattern (focal vs diffuse), and location were reported. AF types were determined using patient’s electronic medical records. Results: One hundred and twenty-six patients (age 67 ± 12 years, 26% female, BMI 29.8 ± 6.5 kg/m2) were included in the study. 35 pts (27.4%) met diagnostic criteria for cardiac sarcoidosis (CS). 79 (62.7%) patients had pAF, 39 (31%) had perAF, 8 (6.3%) had an unspecified subtype. Atrial avidity was seen in 45 patients and distributed accordingly: 30 in the right atrium, 13 bi-atrial, and 2 left atrial. Avidity had a predominant diffuse pattern (66.7%) with intensity equal or greater than the liver’s (62%). 23 (58%) of the avid atria were in perAF patients while only 22 (38%) were in pAF patients. Quantitively, aTBRmax was significantly higher in perAF group (1.35 ± 0.51 vs 1.14 ± 0.39, p=0.03). PerAF was associated with a higher aTBRmax (B=0.2, CI 0.03-0.37, p=0.02) after adjusting for cardiac sarcoidosis. Conclusion: Persistent AF is associated with higher qualitative and quantitative atrial FDG-PET avidity compared to paroxysmal AF. Additional studies are needed to better understand causality and mechanisms behind these associations.

CirculationVol. 152(Suppl_3)
University of Washington (US)
Openalex Percentile: Top 60%
Sarcoidosis and Beryllium Toxicity Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.